Quick Answer
Organogenesis Holdings Inc. reported Common Stock Shares Outstanding of 126.95 million shares for the year ending 2025.
- Organogenesis Holdings Inc. showed an increase of +1.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Organogenesis Holdings Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: 91.32 million shares | Q2 2019: 91.34 million shares | Q3 2019: 94.74 million shares | Q1 2020: 105.36 million shares | Q2 2020: 105.42 million shares | Q3 2020: 107.46 million shares | Q1 2021: 128.10 million shares | Q2 2021: 128.28 million shares | Q3 2021: 128.64 million shares | Q1 2022: 128.89 million shares | Q2 2022: 130.89 million shares | Q3 2022: 130.92 million shares | Q1 2023: 131.23 million shares | Q2 2023: 131.31 million shares | Q3 2023: 131.31 million shares | Q1 2024: 132.54 million shares | Q2 2024: 132.57 million shares | Q3 2024: 132.58 million shares | Q1 2025: 126.85 million shares | Q2 2025: 126.85 million shares | Q3 2025: 126.91 million shares.
- Over the full 9 years of available data (2017 to 2025), Organogenesis Holdings Inc.'s Common Stock Shares Outstanding has grown by 89.5%.
- Historical annual values: Fiscal year 2025: 126.95 million shares | Fiscal year 2024: 125.73 million shares | Fiscal year 2023: 131.32 million shares | Fiscal year 2022: 130.92 million shares | Fiscal year 2021: 128.68 million shares | Fiscal year 2020: 127.73 million shares | Fiscal year 2019: 104.87 million shares | Fiscal year 2018: 91.26 million shares | Fiscal year 2017: 66.98 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: